Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (151-160 of 329) with videos related to

Pageof 33
Sort By:
Microbiology Spectrum|September 20, 2022
Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 VariantThéophile Cocherie, Mathilda Bastide, Soraya Sakhi, et al.
Angewandte Chemie (International Ed. in English)|July 15, 2026
Virus-Mediated Self-Assembly of Functional Cyclodextrins for Antiviral InhibitionPedro J Hernando, Laora Boulo, Léonid Lavnevich, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Cécile Dalban, Gilles Peytavin, et al.
AIDS (London, England)|September 15, 2004
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20Anne-Geneviève Marcelin, Jacques Reynes, Sabine Yerly, et al.
AIDS (London, England)|January 6, 2016
Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoirRuxandra Calin, Chiraz Hamimi, Sidonie Lambert-Niclot, et al.
Antiviral Therapy|August 20, 2003
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial)Constance Delaugerre, Karine Gourlain, Roland Tubiana, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2024
The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen typeElisa Teyssou, Cathia Soulie, Antoine Fauchois, et al.
AIDS (London, England)|June 15, 2012
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposureSlim Fourati, Isabelle Malet, Sidonie Lambert, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2022
More HIV-1 RNA detected and quantified with the Cobas 6800 system in patients on antiretroviral therapyMarc Wirden, Romain Palich, Basma Abdi, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivoOlivier Delelis, Sylvain Thierry, Frédéric Subra, et al.
Pageof 33

Showing results (151-160 of 329) with videos related to

Sort By:
Pageof 33
Microbiology Spectrum|September 20, 2022
Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 VariantThéophile Cocherie, Mathilda Bastide, Soraya Sakhi, et al.
Angewandte Chemie (International Ed. in English)|July 15, 2026
Virus-Mediated Self-Assembly of Functional Cyclodextrins for Antiviral InhibitionPedro J Hernando, Laora Boulo, Léonid Lavnevich, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Cécile Dalban, Gilles Peytavin, et al.
AIDS (London, England)|September 15, 2004
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20Anne-Geneviève Marcelin, Jacques Reynes, Sabine Yerly, et al.
AIDS (London, England)|January 6, 2016
Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoirRuxandra Calin, Chiraz Hamimi, Sidonie Lambert-Niclot, et al.
Antiviral Therapy|August 20, 2003
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial)Constance Delaugerre, Karine Gourlain, Roland Tubiana, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2024
The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen typeElisa Teyssou, Cathia Soulie, Antoine Fauchois, et al.
AIDS (London, England)|June 15, 2012
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposureSlim Fourati, Isabelle Malet, Sidonie Lambert, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2022
More HIV-1 RNA detected and quantified with the Cobas 6800 system in patients on antiretroviral therapyMarc Wirden, Romain Palich, Basma Abdi, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivoOlivier Delelis, Sylvain Thierry, Frédéric Subra, et al.
Pageof 33